XPENG INC - ADR (XPEV) Stock Analyst Ratings
USA - NYSE:XPEV - US98422D1054 - ADR
22.43 USD
-2.58 (-10.32%)
22.65 USD
+0.22 (+0.98%)
ChartMill assigns a Buy % Consensus number of 78% to XPEV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 25.96. This target is 15.72% above the current price.
XPEV was analyzed by 33 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about XPEV.
In the previous month the buy percentage consensus was at a similar level.
XPEV was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-15 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-05-22 | Macquarie | Upgrade | Neutral -> Outperform |
| 2025-03-20 | Barclays | Maintains | Underweight -> Underweight |
| 2025-03-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-10 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-02-24 | UBS | Upgrade | Sell -> Neutral |
| 2025-02-07 | Macquarie | Downgrade | Outperform -> Neutral |
| 2024-12-05 | UBS | Downgrade | Neutral -> Sell |
| 2024-11-22 | China Renaissance | Upgrade | Hold -> Buy |
| 2024-11-20 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2024-11-20 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-09-05 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-08-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-21 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-07-16 | B of A Securities | Maintains | Buy -> Buy |
| 2024-06-25 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-04-15 | Macquarie | Reiterate | Neutral |
| 2024-03-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-02-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-09-22 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-08-22 | Barclays | Maintains | Underweight -> Underweight |
| 2023-08-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-21 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-08-08 | CLSA | Upgrade | Outperform -> Buy |
| 2023-08-07 | HSBC | Upgrade | Hold -> Buy |
| 2023-08-02 | Citigroup | Maintains | Sell -> Sell |
XPENG INC - ADR / XPEV FAQ
Can you provide the average price target for XPENG INC - ADR stock?
33 analysts have analysed XPEV and the average price target is 25.96 USD. This implies a price increase of 15.72% is expected in the next year compared to the current price of 22.43.
How do analysts rate XPENG INC - ADR (XPEV)?
The consensus rating for XPENG INC - ADR (XPEV) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed XPENG INC - ADR (XPEV)?
The number of analysts covering XPENG INC - ADR (XPEV) is 33.